Showing results (11-20 of 148) with videos related to
Sort By:
Pageof 15
Atherosclerosis|February 17, 2019
HDL cholesterol and ASCVD risk stratification: A debatePhilip Barter, Jacques GenestJournal of Atherosclerosis and Thrombosis|August 19, 2014
Antioxidant effects of statins in the management of cardiometabolic disordersSoo Lim, Philip BarterTrends in Pharmacological Sciences|November 18, 2011
Cholesteryl ester transfer protein inhibition to reduce cardiovascular risk: Where are we now?Philip Barter, Kerry-Anne RyeThe American Journal of Cardiology|October 22, 2008
Effectiveness of combined statin plus omega-3 fatty acid therapy for mixed dyslipidemiaPhilip Barter, Henry N GinsbergDiabetes Care|May 30, 2006
Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) studyJames Shepherd, Philip Barter, Rafael Carmena, et al.Journal of the American College of Cardiology|May 17, 2008
Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgerySanjiv J Shah, David D Waters, Philip Barter, et al.Plos One|May 23, 2012
Phenotypic and functional changes in blood monocytes following adherence to endotheliumColin Tso, Kerry-Anne Rye, Philip BarterThe American Journal of Geriatric Cardiology|May 11, 2004
A prospective study of pravastatin in the elderly at risk: new hope for older personsJames ShepherdAtherosclerosis. Supplements|July 28, 2005
Does statin monotherapy address the multiple lipid abnormalities in type 2 diabetes?James ShepherdAtherosclerosis. Supplements|February 26, 2004
Preventing the next event in the elderly: the PROSPER perspectiveJames ShepherdPageof 15